Simon Read, Chief Scientific Officer at Ra Pharmaceuticals, Inc. (RARX), sold 10,000 shares at $46.68 ($467K) on 2019-11-14, disclosed to the SEC on 2019-11-18.
Open-market sale of $467k RARX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RARX | SELL | 2019-12-18 | $471K | — | Filing → |
| RARX | SELL | 2019-10-17 | $469K | — | Filing → |
| RARX | SELL | 2019-09-16 | $254K | — | Filing → |